# The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women

> **NCT06556342** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 198 (estimated)

## Conditions studied

- Ovary Cancer

## Interventions

- **DRUG:** FRD001

## Key facts

- **NCT ID:** NCT06556342
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2024-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556342, "The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06556342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*